Tag Archives: FDA

BIO Testifies at 21st Century Cures Hearing on PCAST

TheHill

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing. The Hearing focused on the President’s Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation and key issues related to the 21st Century Cures initiative to examine what steps the Committee can take to accelerate the pace of cures in America. Below is a summary: The Challenge of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Driving Innovation through Federal Investments

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving innovation through federal investments. Below are highlights of our written testimony. NIH:  A Driver of the Innovation Pipeline We must continue to invest in scientific discovery.  NIH-supported biomedical research builds the foundation of scientific and clinical knowledge that is widely communicated and used to improve the treatment of patients and underpin the development of new diagnostics, treatments, vaccines, and cures. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Calls on Appropriators to Fully Fund FDA

cells115x76

BIO issued letters today encouraging support for programs and initiatives of critical importance to our industry as appropriators develop the Fiscal Year 2015 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. Perhaps most importantly, we emphasize the importance of a strong, fully-funded FDA with the resources necessary to keep pace with rapidly-evolving biomedical science and to make sound regulatory decisions in a timely and efficient manner. We are requesting a total Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

“No Need to Label GMOs” Says FDA

peggy-hamburg-115x76psd

The Nation’s Leading Regulatory Body on Food Safety Reaffirms Safety of GMOs On March 28, 2014, the Food and Drug Administration Commissioner Margaret Hamburg testified to the House Appropriations Committee on the FDA’s 2015 budget request. In a line of questioning, she was asked about the labeling of GMOs. The Hill’s Benjamin Goad tracked her response reaffirming that the FDA will not label GM foods. “Margaret Hamburg told lawmakers this week that the agency remains Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

FDA: Vaccines a Critical Tool in Protecting and Promoting Public Health

FDA115x76

Yesterday, Dr. Karen Midthun of the FDA wrote about the important role of vaccines in promoting public health: Vaccines are a critical tool in protecting and promoting the public health in the U.S. and around the world. The risks from childhood diseases like measles, mumps and polio have been greatly reduced, or in the case of polio, eliminated in the U.S. Vaccines are one of the great public health success stories of the 20th century. Dr. Midlun Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,